Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0003320,
umls-concept:C0007600,
umls-concept:C0016343,
umls-concept:C0016360,
umls-concept:C0017262,
umls-concept:C0021745,
umls-concept:C0086418,
umls-concept:C0185117,
umls-concept:C0205195,
umls-concept:C0334227,
umls-concept:C0441833,
umls-concept:C1280500,
umls-concept:C1514485,
umls-concept:C1527249,
umls-concept:C1999270,
umls-concept:C2911684
|
pubmed:issue |
5
|
pubmed:dateCreated |
1991-8-20
|
pubmed:abstractText |
Gamma-Interferon (IFN-gamma) and the antimetabolites 5-fluorouracil (5-FU) and 5-fluoro-2'-deoxyuridine (FUdR) were investigated as individual agents and in combination for their in vitro antiproliferative capacity and for their effect on the expression of HLA class-I antigen, carcinoembryonic antigen (CEA) and the intracellular tumor-associated antigen CTA-I in 7 human colorectal cancer cell lines: WiDr, HT29, Colo 205, SW116, LS174T, SW1398, and LoVo. Growth inhibition by IFN-gamma at clinically relevant concentrations (50-100 U/ml) was found in 4/7 cell lines. The cell lines were equally sensitive to 5-FU (IC50 in a range of 2-10 microM), while sensitivity to FUdR varied considerably (IC50 in a range of 0.01-90 microM). When 50 U/ml IFN-gamma were combined with 5-FU or FUdR, the antiproliferative effects were synergistic in those cell lines with sensitivity to IFN-gamma as a single agent, but not in the IFN-gamma-insensitive cell lines. IFN-gamma was able to enhance the expression of HLA Class I and CEA in 4/7 and 3/7 cell lines, respectively, as measured by flow cytometry. CTA-I expression could not be enhanced with IFN-gamma. The expression of the 3 antigens tested was also increased by 5-FU and FUdR. This effect was concentration-dependent in most instances and varied between the individual cell lines. The combination of 50 U/ml IFN-gamma with 25% growth-inhibitory concentration of 5-FU or FUdR for each cell line resulted in an additional increase in antigen expression in 4/7 cell lines. No relation was found between the enhancement of antigen expression and the sensitivity to IFN-gamma or the anti-metabolites. The enhancement in antigen expression also did not show a relationship with changes in cell-cycle distribution upon exposure to IFN-gamma or the anti-metabolites. These results suggest independent mechanisms for the antiproliferative and antigen-enhancing effects of IFN-gamma, 5-FU and FUdR.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Carcinoembryonic Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Floxuridine,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil,
http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class I,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0020-7136
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
9
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
749-56
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1830034-Antibodies, Monoclonal,
pubmed-meshheading:1830034-Carcinoembryonic Antigen,
pubmed-meshheading:1830034-Cell Division,
pubmed-meshheading:1830034-Cell Line,
pubmed-meshheading:1830034-Colonic Neoplasms,
pubmed-meshheading:1830034-Drug Interactions,
pubmed-meshheading:1830034-Drug Screening Assays, Antitumor,
pubmed-meshheading:1830034-Floxuridine,
pubmed-meshheading:1830034-Fluorouracil,
pubmed-meshheading:1830034-Histocompatibility Antigens Class I,
pubmed-meshheading:1830034-Humans,
pubmed-meshheading:1830034-Interferon-gamma,
pubmed-meshheading:1830034-Kinetics,
pubmed-meshheading:1830034-Recombinant Proteins,
pubmed-meshheading:1830034-Rectal Neoplasms
|
pubmed:year |
1991
|
pubmed:articleTitle |
The effects of gamma-interferon combined with 5-fluorouracil or 5-fluoro-2'-deoxyuridine on proliferation and antigen expression in a panel of human colorectal cancer cell lines.
|
pubmed:affiliation |
Department of Oncology, Free University Hospital, Amsterdam, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|